Latest Breaking News On - Sergei stetsenko - Page 7 : comparemela.com

Published: Jan 01, 2021 By Alex Keown ImmunityBio – Fabio M. Benedetti was named chief strategy officer of California-based ImmunityBio. Benedetti will oversee life-cycle management, pipeline and commercial strategy, including medical affairs. Following the completion of ImmunityBio’s proposed merger with NantKwest, Benedetti is expected to assume the role of chief strategy officer of the combined company. Benedetti most recently served as chief medical officer for Apollomics, Inc., where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. He also previously served as Global CMO at Taiho Pharmaceutical Company, Ltd. and CMO for Taiho Oncology, Inc. Prior to Taiho, he held the positions of senior vice president of Clinical Oncology and CMO at Geron Corporation. He also held roles at Onyx Pharmaceuticals, Millennium Pharmaceuticals, Roche and Bristol-Myers Squibb.

New yorkUnited statesZidong zhangKimberly leeCharlotte russelSergei stetsenkoBristol myers squibbBetterlife pharmaGreg garaJohn fahyFabiom benedettiChristina reimerGeron corporationTaiho oncology incDivision of pulmonaryNovotech health